GTx-186 and crizotinib inhibited the proliferation of HCC78 lung cancer cells, which harbors SLC34A2:ROS1 fusion and are dependent on ROS1 for growth [2], with an IC50 value of 293 nM and 495 nM, respectively (Figure 6A). Here, SLC34A2 is linked to lung carcinoma.